Abstract
Conclusions: We previously reported a decrease in toxicity associated with the use of intraoperative treatment planning in PPI. With longer follow-up, our results show that this improvement in toxicity was obtained without any detrimental effect on biochemical control. There was a trend toward an improved bDFS with intraoperative technology that did not reach statistical significance. Our experience therefore suggests an improvement in the therapeutic ratio in PPI when using intraoperative treatment planning, although it remains difficult to dissociate the impact of new technology from the improvement of technical skills of the brachytherapy team with time. Author Disclosure: W. Foster: None. P. Despres: None. A. Martin: None. S. Aubin: None. N. Varfalvy: None. L. Beaulieu: None. E. Vigneault: None.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
